Fawzi Abu Rous, Medical Oncologist at Henry Ford Health, shared Journal of Clinical Oncology’s post on LinkedIn:
“Thank you to Innovative Engagements for the kind invitation to moderate a case-based discussion with friends and colleagues.
We explored a range of clinically relevant cases, including EGFR-positive NSCLC, MET exon 14 skipping NSCLC, and small cell lung cancer, covering key data across first-line combination strategies, maintenance approaches, and management of advanced disease.”
Other articles featuring Fawzi Abu Rous on OncoDaily.
